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Summary
 
Peripheral B cell tolerance was studied in mice of the autoimmune-prone, Fas-deficient MRL/
 
lpr
 
.H-2
 
d
 
 genetic background by introducing a transgene that directs expression of membrane-
bound H-2K
 
b
 
 antigen to liver and kidney (MT-K
 
b
 
) and a second transgene encoding antibody
reactive with this antigen (3-83
 
md
 
, anti-K
 
k,b
 
). Control immunoglobulin transgenic (Ig-Tg)
MRL/
 
lpr
 
.H-2
 
d
 
 mice lacking the K
 
b
 
 antigen had large numbers of splenic and lymph node B
cells bearing the transgene-encoded specificity, whereas B cells of the double transgenic (Dbl-
Tg) MRL/
 
lpr
 
.H-2
 
d
 
 mice were deleted as efficiently as in Dbl-Tg mice of a nonautoimmune
B10.D2 genetic background. In spite of the severely restricted peripheral B cell repertoire of
the Ig-Tg MRL/
 
lpr
 
.H-2
 
d
 
 mice, and notwithstanding deletion of the autospecific B cell popula-
tion in the Dbl-Tg MRL/
 
lpr
 
.H-2
 
d
 
 mice, both types of mice developed lymphoproliferation
and exhibited elevated levels of IgG anti-chromatin autoantibodies. Interestingly, Dbl-Tg
MRL/
 
lpr
 
.H-2
 
d
 
 mice had a shorter lifespan than Ig-Tg MRL/
 
lpr
 
.H-2
 
d
 
 mice, apparently as an in-
direct result of their relative B cell lymphopenia. These data suggest that in MRL/
 
lpr
 
 mice pe-
ripheral B cell tolerance is not globally defective, but that certain B cells with receptors specific
for nuclear antigens are regulated differently than are cells reactive to membrane autoantigens.
Key words: B lymphocyte • tolerance • autoantibody • MRL/
 
lpr
 
 • systemic lupus 
erythematosus
 
T
 
he MRL/
 
lpr 
 
mouse is an intensively studied, but
poorly understood model of SLE. The MRL/
 
lpr
 
 strain
has a variety of genetic defects (1) in addition to carrying
the 
 
lpr
 
 mutation, which is a loss of function allele of the Fas
(CD95) gene. Fas and Fas ligand (FasL)
 
1
 
 are members of
gene families that are important in immune regulation and
cell death (2). The 
 
lpr
 
 mutation protects cells from the nor-
mal death-inducing effects of FasL (3, 4). Although Fas is
functionally expressed on many cell types, 
 
lpr
 
 mice are rela-
tively normal until young adulthood, when they develop
massive lymphadenopathy, hypergammaglobulinemia, and
autoantibodies to a variety of intracellular constituents, in-
cluding chromatin, snRNP, and DNA (1, 5–7). Disease se-
verity is strongly affected by genetic background, and the
MRL background is particularly prone to autoimmunity,
even in the absence of the 
 
lpr
 
 defect (1, 8).
Because intrinsic defects in B and T lymphocytes are re-
quired in 
 
lpr
 
 mice for autoimmune disease to occur (9–16),
and because the 
 
lpr
 
 defect in the Fas-mediated death path-
way promotes autoimmunity, several studies have tested
the possibility that clonal elimination of autoreactive lym-
phocytes might be defective in these
 
 
 
mice (5, 17–23).
 
 
 
In
some studies, central and peripheral T cell tolerance appears
relatively unaffected in 
 
lpr 
 
mice, at least when tested using
antigen receptor Tg systems or with T cell superantigens
(22, 24–26). But there are some notable exceptions to this
general conclusion (21, 27–29), suggesting that at least the
tempo of and sensitivity to deletion may be impaired in 
 
lpr
 
mice.
Parallel studies using B cell receptor (BCR) Tg 
 
lpr 
 
mice
assessed defects in central and peripheral B cell tolerance.
Central tolerance to the non–disease-associated autoanti-
gens H-2
 
k,b
 
 or membrane-bound hen egg lysozyme ap-
peared to be normal (20, 30), whereas tolerance to the lu-
pus-associated autoantigen, double-stranded DNA, was
impaired (31, 32). Therefore, it is possible that nuclear au-
toantigens are the focus of the autoimmune disease because
of an antigen-specific, rather than a global tolerance defect.
 
1
 
Abbreviations used in this paper: 
 
ALT, alanine aminotransferase; AST, as-
parate aminotransferase; BCR, B cell receptor; BGG, bovine 
 
g
 
 globulin;
Dbl-Tg, double transgenic; FasL, Fas ligand; HRP, horseradish peroxi-
dase; Ig-Tg, immunoglobulin transgenic; MT-K
 
b
 
, metallothionein-K
 
b
 
;
Tg, transgenic.
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Clonal Deletion of Fas-deficient B Cells
 
Several studies have shown that mature peripheral B cells
are subject to Fas-induced death subsequent to activation
through CD40 and that this death could be specifically res-
cued by BCR signaling (33–36). In BCR Tg mice in
which B cell anergy develops as a result of exposure to sol-
uble self-antigen, the Fas mutation has little effect until a
cognate B/T interaction is generated, at which point de-
fective BCR signaling in anergic B cells prevents their res-
cue (35). This sensitivity of anergic or antigen nonbinding
B cells to T cell killing is blocked in mice lacking func-
tional Fas or FasL (33–36). Although these studies could
not reveal how the 
 
lpr 
 
defect leads to lupus autoimmunity,
they suggest that a global defect in the ability to eliminate
autoreactive peripheral B cells could be involved. Conse-
quently, antigen-specific or global tolerance defect(s), or
both, may contribute to autoimmunity in the MRL/
 
lpr
 
mouse.
We have previously described a double transgenic (Dbl-
Tg) mouse model of peripheral B cell clonal elimination
(37) in which the anti–H-2K
 
k,b
 
 BCR Ig-Tg mouse called
3-83
 
md
 
 is crossed to the MT-K
 
b
 
 mouse, which expresses
the cognate K
 
b
 
 antigen under the control of the sheep me-
tallothionein promoter (38). In these Dbl-Tg mice, B cells
are efficiently eliminated at some time after export from the
bone marrow, apparently as a result of encounter with
liver-expressed K
 
b
 
 antigen, rendering their lymph nodes
nearly devoid of B cells (37). The death pathway that elim-
inates the autoreactive B cells in this Dbl-Tg model is not
known, but the cells can only be partially rescued by over-
expression of Bcl-2 (39). In this study, we have evaluated
the effect of the MRL/
 
lpr
 
 genetic background on the dele-
tion of autoreactive B cells in this model.
 
Materials and Methods
 
Mice and Their Genetic Typing.
 
All mice were bred and main-
tained under specific pathogen-free conditions at the Biological
Resource Center of the National Jewish Medical and Research
Center (NJMRC, Denver, CO). B10.D2nSn/J mice (henceforth
referred to as B10.D2) were obtained from Jackson Laboratory
(Bar Harbor, ME). B10.D2 congenic mice bearing the 3-83
 
md
 
(anti–H-2K
 
k,b
 
; reference 37) and MT-K
 
b
 
 (38) transgenes were
backcrossed for five generations to the MRL/
 
lpr
 
 (H-2
 
k
 
) back-
ground. To prevent central tolerance on this background, mice
retaining the B10.D2-derived H-2
 
d
 
 locus were used and inter-
bred, yielding partially inbred MRL/
 
lpr
 
.H-2
 
d
 
 mice with or with-
out the 3-83
 
md
 
 Ig or MT-K
 
b
 
 antigen transgenes. All the Ig-Tg
mice analyzed were hemizygous for the 3-83 
 
md
 
 transgene. Seg-
regation of transgenes and Fas alleles (
 
lpr 
 
or wild-type) was fol-
lowed using PCR and Southern blot analysis of tail DNA as de-
scribed (20, 37). The segregation of endogenous H-2
 
k,d
 
 alleles
was followed by flow cytometric analysis of peripheral blood
lymphocytes using specific antibodies.
 
Flow Cytometry.
 
Flow cytometric analysis of lymphoid tissues
was performed as described (20) using a FACScalibur
 
Ò
 
 flow cy-
tometer and PC-LYSIS data analysis software (Becton Dickinson,
San Jose, CA).
 
ELISA Analysis of Serum Immunoglobulins.
 
Sera were taken at
6–8 wk of age (young mice) or 5 mo of age (aged mice). Total
IgG and IgM concentrations were measured by a sandwich
ELISA using specific goat anti–mouse polyclonal reagents (South-
ern Biotechnology Associates, Birmingham, AL). Unlabeled goat
anti–mouse antibodies (10 
 
m
 
g/ml) in PBS were adhered to poly-
styrene Immunolon microtiter plates (Dynatech Laboratories,
Inc., Chantilly, VA) by overnight incubation. Plates were then
washed with washing buffer (PBS and 0.05% Tween-20) and
blocked using PBS, 0.5% BSA, and 0.4% Tween-20. Mouse sera
in diluent (PBS, 0.2% gelatin, and 0.5% bovine 
 
g
 
 globulin
[BGG]) were applied to the plates and incubated overnight. After
extensive washing in washing buffer, bound mouse Ig was de-
tected by incubation for 2 h at room temperature with horserad-
ish peroxidase (HRP)-conjugated goat anti–mouse IgG or IgM
reagents (Southern Biotechnology Associates), followed by wash-
ing in washing buffer and incubation with the colorimetric sub-
strate 2,2
 
9
 
-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS;
Sigma Chemical Co., St. Louis, MO), in McIlvain’s Buffer (84
mM Na
 
2
 
PO
 
4
 
 and 48 mM citrate, pH 4.6) containing 0.005%
H
 
2
 
O
 
2
 
. Absorbance at 410 nm was detected using a spectropho-
tometer (model 2225; Bio-Rad Laboratories, Hercules, CA).
Quantitation of 3-83 clonotype
 
1
 
 IgM antibodies was performed
as described (37). Standard curves for the anti-idiotype and anti-
IgM assays were generated using IgM 3-83 transfectoma (cos
linD) supernatant (40). IgG isolated from culture supernatant of
the 3-83 hybridoma (41) provided the standard for the anti-IgG
assay. Anti-chromatin autoantibody titers were quantitated using
microtiter plates coated with 10 
 
m
 
g/ml mouse thymus–derived
chromatin (a gift of Dr. L. Wysocki, NJMRC) diluted in PBS.
Diluted sera were reacted with the plates for 2 h at room temper-
ature followed by overnight incubation at 4
 
8
 
C. The plates were
washed with washing buffer, and bound mouse antibody was de-
tected as described above. Affinity-purified mouse monoclonal
IgG anti-dsDNA 3H9 (42) served as a positive control, and as a
reference standard curve as described previously (20). Nonspecific
binding was assessed with plates coated with 0.2% gelatin in PBS.
 
Plasma Transaminase Activity.
 
Blood samples were taken by
tail vein sampling or retro-orbital bleed, under Avertin anesthesia
(43). Purified sera samples were separated from the clot within 1 h
and were retained no more than 24 h at 4
 
8
 
C before analysis by a
PARAMAX 720 (Paramax Chemistries AKA Dade-Behring In-
ternational, Inc., Newark, DE), using Dade Alanine and Asparate
Aminotransferase (ALT and AST) Reagent(s), (Dade Interna-
tional, Inc., Aguada, PR; reference 44). Data from serum samples
in which the instrument detected hemolysis were excluded.
 
Analysis of Mouse Survival.
 
Viability of individual mice of the
strains indicated in Fig. 6 was followed over time. Mice were
maintained under uniform environmental conditions throughout.
The study end point event was defined as death. All data on
weeks-followed were calculated from the date of birth, and sur-
vival probabilities were nonparametrically estimated at event
times by the Product-Limit (Kaplan-Meier) method (45) using
JMP data analysis software (SAS Institute, Inc., Cary, NC). Mice
killed because of sickness (for which death could be anticipated
within 24–48 h) were treated as deaths and the lifespans recorded.
Data on animals that were killed for any other reason was censored.
 
Bone Marrow Chimeric Mice.
 
Irradiated recipients were pre-
pared as previously described (46), but without antibiotic prophy-
laxis. Food was withheld from the mice 24 h before irradiation,
and returned immediately after irradiation.
 
 
 
Bone marrow suspen-
sions were isolated from Ig-Tg donors and prepared sterilely as
previously described (46) with some modifications. Cells were
isolated, washed in HBSS, depleted of erythrocytes by Gey’s lysis
buffer, washed, and resuspended at 10
 
8
 
 cells/ml in RPMI and 
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10% FCS. Cell suspensions were incubated for 1 h at 4
 
8
 
C with
the following antibodies at a concentration of 1 
 
m
 
g/10
 
6
 
 cells:
anti-Thy1.1/1.2, T24 (a gift of Uwe Staerz, NJMRC); anti-
Thy.1.2, H0-13-4 (47); anti-B220, RA3-3A1 (48); and anti-
CDw32, 24G.2 (a gift of J. Cambier, NJMRC). After washing,
treated cells were applied to petri dishes (Becton Dickinson) pre-
viously coated with goat anti–rat Ig. Dishes were incubated on
ice for 40 min, swirled and incubated again for another 30 min.
The depleted, nonadherent cell suspensions were collected,
washed and resuspended at 5 
 
3
 
 10
 
7
 
 cells/ml in sterile HBSS and
0.1 ml was injected intravenously per irradiated recipient.
 
Statistical Analysis.
 
Significant differences in serum transami-
nase activities were quantified by a three-way analysis of variance
(ANOVA), using a two-tailed test. Significance with respect to sur-
vival of MRL/
 
lpr
 
 mice was determined using the Log-Rank test. All
data were analyzed using JMP analysis software (SAS Institute, Inc.).
 
Results
 
Analysis of B Cell Tolerance in Young Dbl-Tg MRL/lpr.
H-2
 
d
 
 Mice.
 
To assess if peripheral B cell tolerance is im-
paired on the MRL/
 
lpr
 
 autoimmune-prone genetic back-
ground, we measured depletion of autoreactive B cells in
lymph nodes of 6–8-wk-old Dbl-Tg MRL/
 
lpr
 
.H-2
 
d
 
 mice.
Cells bearing the transgene-encoded BCR were quantified
by flow cytometry using a clonotype-specific mAb (Fig. 1).
As expected from the specificity of this assay, control non-
Tg mice had few cells scoring clonotype
 
1
 
 (Fig. 1, 
 
A
 
 and
 
E
 
), and Ig-Tg mice that lacked cognate antigen had high
levels of clonotype
 
1
 
 B cells on both MRL/
 
lpr
 
.H-2
 
d
 
 and
B10.D2 backgrounds (Fig. 1, 
 
B and F, respectively). In
contrast, antigen-expressing Dbl-Tg MRL/lpr.H-2d as well
as Dbl-Tg MRL/lpr/1.H-2d and Dbl-Tg B10.D2 Fas-suf-
ficient control mice efficiently eliminated clonotype1
lymph node cells (Fig. 1, D, C, and G, respectively). A
characteristic of 3-83md/MT-Kb Dbl-Tg mice is that they
retain a small population of short-lived 3-83 clonotype1
cells in the spleen (37, 39). Since fewer 3-83 clonotype1
cells remained in the spleens of Dbl-Tg MRL/lpr.H-2d
mice than in Dbl-Tg B10.D2 mice (data not shown), dele-
tion appeared to be at least as efficient on the autoimmune-
prone genetic background as on the normal genetic back-
ground. In addition, both Dbl-Tg MRL/lpr.H-2d and Dbl-
Tg B10.D2 strains lacked clonotype1 B cells in their peri-
toneal cavities (data not shown). To detect rare Ig-trans-
genic B cells that may have escaped peripheral tolerance
mechanisms at frequencies below the detection level of our
FACSÒ analyses, we performed an ELISPOT assay de-
signed to reveal clonotype-secreting cells persisting in
lymph node at very low frequencies, but failed to detect
clonotype-secreting cells above background levels (data not
shown). These data indicated that clonal elimination of
transgene-encoded autoreactive B cells proceeded normally
in MRL/lpr.H-2d mice.
Efficient clonal elimination of Fas-deficient B cells that
were autoreactive to the tissue-specific MT-Kb antigen
raised the consideration that expression of this antigen was
altered on the MRL/lpr genetic background compared
with the B10.D2 background. Therefore, we confirmed
the results of the double transgenic approach in short-term
bone marrow chimeras in which Ig-Tg bone marrow cells
of the MRL/lpr.H-2d or B10.D2 genetic background were
used to reconstitute lethally irradiated B10.D2 MT-Kb Tg
recipients (Fig. 2). Regardless of genetic background, au-
tospecific B cells were deleted from the lymph nodes of Ig-
Tg®MT-Kb chimeras tested at 3–4 wk after reconstitu-
tion, whereas control, Ig-Tg®non-Tg lymph nodes had
abundant 3-83 clonotype1 cells. The bone marrows of all
mice were shown to contain an abundance of 3-83 clono-
Figure 1. Absence of 3-83 idiotype1 B cells in the lymph nodes of young Dbl-Tg MRL/lpr.H-2d mice. (A–G) Flow cytometric analysis of lymph
nodes of young (6–8 wk) mice of the indicated genetic backgrounds stained to reveal IgM1 and idiotype1 cells. (H) Summary of the effect of the autoim-
mune background on the percentage of idiotype1 B cells in lymph nodes. D shows representative data from a Dbl-Tg MRL/lpr.H-2d mouse. C shows
representative lymph node cells taken from a Dbl-Tg MRL/lpr/1.H-2d Fas-sufficient control. Data represents the means 6 SE of three independent ex-
periments.912 Clonal Deletion of Fas-deficient B Cells
type1 cells, indicating that the lack of B cells in the MT-Kb
recipient lymph nodes was not the result of inefficient re-
constitution. These data confirm that the antigen dose on
the B10.D2 MT-Kb transgenic background was sufficient to
delete Fas-deficient MRL/lpr.H-2d-derived Ig-Tg B cells.
Analysis of B Cell Tolerance in Aged Dbl-Tg MRL/lpr.H-2d
Mice. Since the lupus-like disease of MRL/lpr mice is age
dependent, we tested the possibility that Dbl-Tg MRL/
lpr.H-2d mice had an age-dependent defect in peripheral B
cell tolerance by analyzing lymph nodes of 5–7-mo-old
mice for the appearance of 3-83 clonotype1 B cells. The
percentages of transgenic B cells observed in lymph nodes of
aged mice are indicated in Fig. 3 and the absolute 3-83md1
B cell numbers in all mouse age groups analyzed are shown
in Fig. 4. Similar to the results obtained in young Dbl-Tg
MRL/lpr.H-2d mice, lymph nodes of the older mice were
virtually devoid of 3-83 clonotype1 cells (Fig. 3). Addi-
tionally, ELISPOT assay failed to reveal any rare 3-83 anti-
body-forming cells and 3-83–positive B cells were absent
from the peritoneums of these aged Dbl-Tg MRL/lpr.H-2d
mice (data not shown). The aged Dbl-Tg MRL/lpr.H-2d
also had no increase in the percentage of clonotype1 B cells
in their spleens compared with Dbl-Tg B10.D2 mice. A
small, but variable population of B cells expressing very
low levels of transgenic Ig was observed in livers of Dbl-Tg
mice of both autoimmune and nonautoimmune genetic
backgrounds (data not shown). Collectively, these data sug-
gest that throughout the life of the Dbl-Tg MRL/lpr.H-2d
mouse B cells bearing the 3-83 BCR are generated in the
bone marrow and are subsequently deleted upon contact
with peripheral autoantigen. As we show below, this oc-
curs in spite of the ongoing inflammatory and anti-nuclear
antibody responses of Dbl-Tg MRL/lpr.H-2d mice.
Dbl-Tg MRL/lpr.H-2d Sera Lack 3-83 (Auto)antibodies.
Using serum ELISA, we verified the prediction that Dbl-
Tg MRL/lpr.H-2d sera were devoid of 3-83 antibodies. As
expected, the sera of 3-83md Ig-Tg mice lacking the MT-Kb
antigen transgene contained easily detectable levels of 3-83
clonotype antibodies, with equivalent serum concentra-
tions in young mice of both genetic backgrounds. Interest-
ingly, idiotype concentrations in aged MRl/lpr.H-2d Ig-Tg
were increased several-fold over B10.D2 Ig-Tg controls
(Table 1). More importantly, most of these same sera from
older MRL/lpr.H-2d Tg or non-Tg mice contained high
titers of anti-chromatin autoantibodies (see below).
Dbl-Tg and Ig-Tg MRL/lpr.H-2d Mice Develop Autoimmune
Disease. Young or aged Ig-Tg and Dbl-Tg MRL/lpr.H-2d
Figure 2. Absence of 3-83 idiotype1 B cells in the lymph nodes of Ig-
Tg® MT-Kb bone marrow chimeric mice. Flow cytometric analysis of B
cells isolated from the lymph nodes of chimeric mice. Lymph node cells
were stained to reveal IgM1 and idiotype1 B cells.
Figure 3. Efficient deletion of 3-83 idiotype1 B cells in the lymph nodes of aged Dbl-Tg MRL/lpr.H-2d mice. (A–F) Flow cytometric analysis of
lymph node cells of 5–7-mo-old mice of the indicated genetic backgrounds. Also shown are lymph node cells of age-matched B10.D2 controls. (G)
Summarized data represents the means 6 SE of five independent experiments.913 Kench et al.
mice had high levels of IgG anti-chromatin, whereas Fas-
sufficient MRL Dbl-Tg or B10.D2 background mice lacked
anti-chromatin autoantibodies (Fig. 5). These increases in
autoantibody titers were associated with a modest degree of
IgG hypergammaglobulinemia (Table 1). Thus, in Dbl-Tg
MRL/lpr.H-2d mice that properly controlled transgene-
encoded autoreactive B cells, rare B cells reactive to chro-
matin were functional and specifically activated.
Since anti-nuclear autoantibodies are diagnostic of both
murine and human lupus nephritis (49, 50), we assessed kid-
ney function by measuring levels of proteinuria. Older
MRL/lpr.H-2d mice had elevated levels of protein in the
urine (data not shown), indicating that this increase was cor-
related with Fas-insufficiency rather than transgene genotype.
Because MRL/lpr (H-2k) mice die prematurely from au-
toimmune glomerulonephritis (1), we compared longevity
of non-Tg and Tg MRL/lpr.H-2d mice to the parental (H-
2k) MRL/lpr strain and to the central tolerance model
strain, Ig-Tg MRL/lpr (H-2k) (Fig. 6 B). All lpr mice died
prematurely compared with Fas-sufficient controls (not
shown), but non-Tg and Ig-Tg MRL/lpr.H-2d mice lived
significantly longer than the MHC-disparate Ig-Tg MRL/
lpr (H-2k) strain (P 5 0.0001) or the parental (H-2k) MRL/
lpr strain (1). In the non-Tg and Ig-Tg MRL/lpr.H-2d
groups  .50% of the mice remained alive at 40 wk. Surpris-
ingly, Dbl-Tg MRL/lpr.H-2d mice had a median lifespan
of only 27 wk which was significantly shorter (P 5 0.02)
than the lifespans of MRL/lpr.H-2d non-Tg mice or Tg
Figure 4. Ig-Tg MRL/lpr.H-2d mice produce comparable numbers of
idiotype1 B cells compared with B10.D2 controls. Absolute numbers
of idiotype1 B cells in the lymph nodes was calculated as (total cells) 3 (%
idiotype1) as determined by FACSÒ analyses. Total cells represents pooled
cells from the inguinal, brachial, axillary and mesenteric lymph nodes of
each mouse tested. Data represents the means 6 SE of three (young mice)
and five (aged mice) independent experiments.
Table 1. Effect of Transgenes on Serum Immunoglobin Concentrations in the Autoimmune MRL/lpr.H-2d Genetic Background
Type n Strain 3-83 Idiotype IgM IgG
6–8 wk mg/ml mg/ml mg/ml
Non-Tg 2 MRL/lpr.H-2d 0.6(0.2) 923(178) .5500
Ig-Tg 4 MRL/lpr.H-2d 11(7) 177(78) 2417(810)
Dbl-Tg 3 MRL/lpr/1.H-2d ,0.4* 70(30) 1150(826)
Dbl-Tg 3 MRL/lpr.H-2d ,0.4 48(14) 1292(424)
Non-Tg 3 B10.D2 ,0.4 441(108) 1145(355)
Ig-Tg 3 B10.D2 13(4) 197(9) 389(107)
Dbl-Tg 3 B10.D2 1.0(0.6) 545(338) 291(35)
5–7 mo
Non-Tg 7 MRL/lpr.H-2d ,0.4 1088(283) 3441(1026)
Ig-Tg 6 MRL/lpr.H-2d 68(22) 313(165) 2667(217)
Dbl-Tg 6 MRL/lpr.H-2d ,0.4 194(63) 1645(734)
Non-Tg 4 B10.D2 ,0.4 310(91) 439(102)
Ig-Tg 4 B10.D2 16(3) 239(34) 1228(339)
Dbl-Tg 5 B10.D2 ,0.4 476(175) 273(105)
Serum immunoglobulin analysis of MRL/lpr.H-2d and B10.D2 mice bearing the indicated transgenes. 3-83 idiotype, IgM and IgG concentrations
were measured using ELISA. Data represent the means (SE) of several independent experiments. Bolded items refer to moderate IgG hypergamma-
globulinemia in young and aged mice.
*Minimum detection level of the assay.914 Clonal Deletion of Fas-deficient B Cells
mice bearing only one of either of the transgenes. It appears
that potential autoreactivity of the B cells or the B cell lym-
phopenia in these Dbl-Tg mice contributed to their short-
ened lifespan.
We examined the livers of Dbl-Tg MRL/lpr.H-2d and
control mice because this tissue was the predicted site at
which transgene-encoded autoreactive B cells could poten-
tially cause pathology and because MRL/lpr mice develop
inflammation in many organ systems as part of their au-
toimmune disease (1). All histologically examined lpr livers
exhibited moderate to severe disease, including the pres-
ence of infiltrating inflammatory cells with small foci of
large lymphocytes and neutrophils throughout the paren-
chyma, along with a highly diffuse perivascular response, all
indicating disseminated hepatitis and massive damage (data
not shown; Henson, P., personal communication). To
quantify liver damage in the mouse strains of interest, we
chose to measure plasma concentrations of the liver en-
zymes ALT and AST. Whereas young MRL/lpr.H-2d mice
exhibited enzyme activities no different than B10.D2 mice,
the circulating levels of either or both AST (P 5 0.002) and
ALT (P 5 0.04) were elevated in aged MRL mice, regard-
less of Tg genotype (Table 2), confirming the presence of
liver damage in these mice, and suggesting that this damage
was not specifically exacerbated in the Dbl-Tg individuals.
Lymphoproliferation. Mice of the various experimental
groups were tested for evidence of lymphoid hyperplasia
(Fig. 6 A), which is a reproducible characteristic of older lpr
mice (1). Aged non-Tg and Tg MRL/lpr.H-2d mice ex-
hibited greatly elevated numbers of lymph node cells rela-
tive to B10.D2 and MRL/lpr/1.H-2d controls.
Discussion
Despite the indications from other studies that Fas-medi-
ated cell death can play an important role in B and T cell
peripheral immune tolerance and the clear ability of the lpr
mutation to cause accelerated lupus-like autoimmunity, in
this study, we find that B cell clonal elimination induced by
liver-expressed membrane protein was not impaired in the
absence of Fas. Similar studies have indicated that both B
cell anergy and central tolerance are barely affected in lpr
mice (19, 20). In our prior analysis of central tolerance (20)
and in this study lpr mice tolerant with respect to the Ig
transgene-encoded antigen specificity nevertheless mani-
fested high titer autoantibodies to nuclear antigens as well
as tissue destruction and premature death. Since in Dbl-Tg
MRL/lpr.H-2d mice liver damage and inflammation was
extensive, yet B cell tolerance to the liver expressed Kb
molecule was efficient, it would appear that tissue damage
and inflammation alone cannot rescue autoreactive B cells
from peripheral tolerance. This observation places severe
constraints on models of autoimmunity that rely on the
concept of tissue damage- or danger-induced adjuvanticity
(51), at least as these concepts relate to B lymphocytes.
Complete ablation of the B cell compartment in JH-
deficient MRL/lpr mice has been shown to rescue the ani-
mals from their autoimmunity (12), suggesting that B cells
Figure 5. Effect of genetic background and transgenes on development
of IgG anti-chromatin autoantibodies. Serum antibody was quantified by
ELISA. 
Figure 6. Effect of transgenes on autoimmune disease in MRL/lpr.H-2d
mice. (A) Effect of transgenes and the MRL/lpr genetic background on
lymph node hyperplasia. Data represent the means 6 SE of three (young
mice) and five (aged mice) experiments. (B) Survival of the various mouse
strains. Inset shows number of mice/group.915 Kench et al.
or their antibody products are required for lupus disease. At
variance with prior studies involving lpr mice that were Ig
transgenic or B cell deficient (12, 19), our experiments us-
ing single and Dbl-Tg MRL/lpr.H-2d mice demonstrate
that restriction of the peripheral B cell repertoire by Ig
transgenesis does not significantly rescue these animals from
lupus-like disease and, as demonstrated by the reduced sur-
vival of the Dbl-Tg MRL/lpr.H-2d mice, may in fact accel-
erate death. Because in these latter mice B cells of the 3-83
Tg specificity appeared to be appropriately tolerized in all
tissues examined, we suspect that the lifespan of the MRL/
lpr.H-2d Dbl-Tg is somehow further shortened as an indi-
rect consequence of its B cell lymphopenia, rather than as a
result of secretion of 3-83 autoantibody.
How can reducing the transgenic B cell population
shorten the lifespan of the MRL/lpr.H-2d Dbl-Tg mice?
One possibility is that this exacerbates lupus autoimmunity.
In some circumstances the presence of an excess of nonau-
toreactive B cells can inhibit the survival of autoreactive B
cells (52, 53). It is also known that resting, but not activated,
B cells can tolerize T cells to MHC class II–restricted anti-
gens (54). If most B cells generated in the Ig-Tg or non-Tg
MRL/lpr.H-2d mice are nonautoreactive, they may tend
to suppress the rare autoreactive cells. By contrast, in the
Dbl-Tg MRL/lpr.H-2d mice, such a pool of “inert” nonauto-
reactive cells is lacking. We speculate that the reduction in
nonautoreactive B cell numbers in Dbl-Tg MRL/lpr.H-2d
mice may improve the fitness or enhance the generation of
the autoreactive B cells that eventually develop.
Autoantibody production in the MRL/lpr mouse relies
upon a cognate, MHC-restricted T cell–B cell interaction (55)
suggesting that the peripheral T lymphocyte repertoire in
MRL/lpr mice includes T cells that are able to provide help to
B cells with antinuclear specificities. If peripheral T cell toler-
ance in these mice is otherwise intact, B cells that are auto-
reactive for other self-antigens such as H-2K molecules may
be tolerized by the absence of T cell help. However, a num-
ber of studies have shown that ab-T cell–independent mech-
anisms may drive some aspects of lupus-like autoimmune
disease, not only in the MRL mouse (56), but on nonauto-
immune murine genetic backgrounds as well (57, 58). There-
fore, peripheral B cell reactivity to certain self-antigens in the
MRL strains could be independent of ab-T cell help. Fur-
thermore, a recent study by Chan and Shlomchik (59) sug-
gests that B cells may act as APC and activate naive CD41 T
cells in MRL/lpr mice. Therefore, it is possible that the lim-
ited B cell repertoire in our peripheral tolerance model con-
tains subpopulations with antinuclear specificities that may be
independent of classical ab-T cell helper mechanisms, or may
be able to activate appropriate CD41 ab-T cell help and
thereby expand autoreactive clones.
Ig-Tg MRL/lpr (H-2k) mice had a lifespan comparable to
the wild-type MRL/lpr (H-2k) strain, whereas survival rates of
MRL/lpr.H-2d mice that were non-Tg, Ig-Tg, or MT-Kb-Tg
were improved (Fig. 6 B). An obvious difference between
Ig-Tg and parental MRL/lpr (H-2k) strains compared with
the Tg mice examined in this study is the substitution of
H-2d for H-2k at the MHC loci and a prior study found that
B6/lpr.H-2d congenic mice have less severe autoimmune
disease than B6/lpr (H-2b) mice (60). However, it should be
noted that we failed to observe a direct correlation between
survival and anti-chromatin antibody titers.
In summary, we have demonstrated that there is no glo-
bal defect in the ability of MRL/lpr mice to eliminate au-
toreactive B cells. However, in spite of ongoing deletion of
self-reactive B cells newly exported from the bone marrow,
aging MRL/lpr.H-2d Dbl-Tg mice develop various charac-
teristics of lupus-like autoimmune disease, including the
production of anti-chromatin autoantibodies, indicating the
presence of autoreactive B cells. Others have shown that
anti–DNA-Tg B cells were not only present and persistent
as a functionally inactivated population in the periphery of
nonautoimmune mice (61, 62), but also that anti–DNA-Tg
B cells experienced selective clonal expansion in the au-
toimmune MRL/lpr genetic background (32). Perhaps
MRL/lpr anti-DNA B cells not only circumvent central and
peripheral tolerance mechanisms, but also exploit some acti-
vation process that is not useful to other autoreactive B cells
that are sensitive to tolerance mechanisms.
Table 2. Transgene Effect on Aminotransferase Concentrations in 
the Sera of Autoimmune MRL/lpr.H-2d Mice
Type n Strain
AST
U/L
ALT
U/L
6–8 wk
Non-Tg 3 MRL/lpr.H-2d 4.0 (0.1) 3.5 (0.2)
Ig-Tg 6 MRL/lpr.H-2d 4.1 (0.1) 3.6 (0.2)
MT-Kb-Tg 7 MRL/lpr.H-2d 4.1 (0.1) 3.5 (0.1)
Dbl-Tg 6 MRL/lpr.H-2d 4.1 (0.1) 3.6 (0.2)
Non-Tg 3 B10.D2 3.6 (0.1) 3.2 (0.1)
Ig-Tg 4 B10.D2 3.8 (0.1) 3.5 (0.1)
MT-Kb-Tg 6 B10.D2 4.1 (0.2) 3.4 (0.1)
Dbl-Tg 6 B10.D2 4.1 (0.1) 3.7 (0.1)
5–7 mo
Non-Tg 7 MRL/lpr.H-2d 4.6 (0.2) 3.7 (0.4)
Ig-Tg 4 MRL/lpr.H-2d 4.6 (0.4) 4.5 (0.5)
MT-Kb-Tg 10 MRL/lpr.H-2d 4.3 (0.3) 3.5 (0.1)
Dbl-Tg 7 MRL/lpr.H-2d 4.5 (0.3) 4.2 (0.3)
Non-Tg 5 B10.D2 3.7 (0.1) 3.3 (0.1)
Ig-Tg 7 B10.D2 3.9 (0.1) 3.5 (0.1)
MT-Kb-Tg 4 B10.D2 4.1 (0.2) 3.6 (0.2)
Dbl-Tg 6 B10.D2 4.2 (0.1) 3.8 (0.2)
Aging MRL/lpr.H-2d mice exhibit high levels of the liver aminotrans-
ferases AST and ALT in circulation. Serum samples from individual
mice of the indicated genotypes were assayed for transaminase activities
as described in Materials and Methods. Bolded items refer to values in
MRL mice which are significantly increased over values in B10.D2
mice. Data are log-transformed and represent the means (SE) of several
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